Corbus Pharmaceuticals Holdings, Inc. Shareholders' Equity
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Shareholders' Equity of $102.24 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $102.24M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $126.34M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $147.50M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $92.15M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $102.24M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $126.34M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $147.50M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $92.15M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $110.99M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $127.11M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $142.43M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $150.50M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $125.54M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $96.97M 10-Q · filed 2025-08-05 | $96.97M 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$6.91M 10-K · filed 2026-03-09 | -$6.90M 10-K · filed 2024-03-12 |
| 2023-09-30 | $312.00K 10-Q · filed 2024-11-07 | $311.02K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $9.52M 10-Q · filed 2024-11-07 | $9.52M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $16.46M 10-Q · filed 2024-08-06 | $16.46M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $32.99M 10-K · filed 2025-03-11 | $32.99M 10-K · filed 2023-03-07 |
| 2022-09-30 | $41.95M 10-Q · filed 2023-11-07 | $41.95M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $49.47M 10-Q · filed 2023-11-07 | $49.47M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $61.16M 10-Q · filed 2023-08-08 | $61.16M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $69.11M 10-K · filed 2024-03-12 | |
| 2021-09-30 | $77.63M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $76.96M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $91.52M 10-Q · filed 2022-08-09 | |
| 2020-12-31 | $45.27M 10-K · filed 2023-03-07 | |
| 2020-09-30 | $29.23M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $48.41M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $22.69M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $6.16M 10-K · filed 2022-03-08 | |
| 2019-09-30 | $29.64M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $47.37M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $42.30M 10-Q/A · filed 2020-08-31 | |
| 2018-12-31 | $27.52M 10-K · filed 2021-03-15 | |
| 2018-09-30 | $42.87M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $55.49M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $65.54M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $57.78M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $31.98M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $37.59M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $43.59M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $8.92M 10-K · filed 2019-03-12 | |
| 2016-09-30 | $13.31M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $17.65M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $6.40M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $8.99M 10-K · filed 2018-03-12 | |
| 2015-09-30 | $11.17M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $6.77M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $4.69M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $5.86M 10-K · filed 2018-03-12 | |
| 2014-09-30 | $7.02M 10-Q · filed 2014-11-13 | |
| 2013-12-31 | -$1.78M 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |